Novo Nordisk stock took a big hit early Tuesday after the Danish weight-loss drugmaker unexpectedly cut its full-year guidance for the U.S.It also announced a new CEO, appointing an insider to lead ...

The Danish firm blamed the move to slash its guidance on intense competition from rivals and copycat drugs in the US.

I’m taking you through where and how corn gets processed—from the field to the final product. Discover the journey of this staple crop!

If you’ve spent any time in the real world lately, chances are you’ve heard of Ozempic, Wegovy, Mounjaro or semaglutide.

Knockoff copies of Novo’s weight loss medicine Wegovy have held back sales and put the drugmaker on the back foot in its ...